NCT06696963View on ClinicalTrials.gov

Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGC

CompletedOBSERVATIONAL
Enrollment

524

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

April 15, 2024

Study Completion Date

April 17, 2024

Conditions
Gastric Cancer
Trial Locations (1)

350001

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University

OTHER

NCT06696963 - Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGC | Biotech Hunter | Biotech Hunter